I
nositol polyphosphate multikinase (IPMK, also known as IPK2 and Arg82) is the primary generator of inositol 1,3,4,5,6-pentakisphosphate (IP5) from either of inositol 1,4,5,6-tetrakisphosphate or inositol 1,3,4,5-tetrakisphosphate (IP4 isomers), although it can also form IP4 from inositol 1, 4, 5-trisphosphate.
1,2 IPMK is essential for embryogenesis because its deletion results in multiple developmental defects and death at embryonic day 9.5. 2 In Drosophila, IPMK is required for imaginal disc development. 3 IPMK is predominantly localized in nuclear compartments 4 and possesses nuclear PI3 kinase activity. 5 A family of inositol phosphates serves multiple functions, including the release of calcium by inositol 1, 4, 5-trisphosphate, while IP4 acts as an intermolecular glue for the assembly of a histone deacetylase complex. 6 IP5, which is generated from IP4, exerts antineoplastic effects. 7, 8 Inositol hexakisphosphate (IP6), which is generated from IP5, has been shown to suppress cancer growth. 9 5-Diphosphoinositol pentakisphosphate, which is generated from IP6, is required for insulin secretion 10 and cell migration. [18] [19] [20] Three isoforms of HIF-α have been identified; the bestcharacterized isoforms are HIF-1α and HIF-2α. 21, 22 HIF-1α is expressed ubiquitously in all cells, whereas HIF-2α and HIF-3α are selectively expressed in certain tissues. 23 HIF-α proteins are constantly degraded under normal conditions. In normoxic environments, HIF-α proteins are hydroxylated by PHD (prolyl hydroxylase domain) proteins at 2 proline residues. [24] [25] [26] [27] Hydroxylated HIF-α is then bound by pVHL (von Hippel-Lindau protein)-the substrate recognition subunit of an E3 ubiquitin ligase. [28] [29] [30] Ubiquitinated HIF-α is subject to proteasomal degradation. Under hypoxic conditions, the activity of PHDs is diminished, leading to stabilization of HIF-α proteins, which heterodimerize with HIF-1β to activate transcription of genes involved in angiogenesis and other homeostatic responses to hypoxia. 21, 23, 31 Three PHDs have been well studied in mammalian cells and shown to utilize oxygen to hydroxylate human HIF-1α at residues P402 and P564. 32, 33 Although all 3 PHDs regulate both HIF-1α and HIF-2α, preferences do exist. PHD2 acts as the major prolyl hydroxylase for HIF-1α, and P564 of HIF-1α is the preferred site for PHD2. [34] [35] [36] By contrast, PHD1 and PHD3 predominantly regulate HIF-2α. 37 Tissue deficiency of PHD2 elicits accumulation of HIF-1α, 38 whereas deficiency of PHD1/PHD3 induces upregulation of HIF-2α. 39 Deletion of PHD2 elicits embryonic lethality, whereas mice with deletion of PHD1 and PHD3 develop normally. 40 Whereas oxygen is a critical factor, diverse proteins and other molecules regulate the enzyme activity of PHDs. For example, OS-9 promotes HIF-1α hydroxylation by directly interacting with both PHDs and HIF-1α, 41 whereas SSAT2 (spermidine/ spermine-N1-acetyltransferase 2) promotes ubiquitination by directly interacting with both pVHL and HIF-1α. 42 We now report that IP5 generated by IPMK is a major regulator of HIF-1α degradation. It acts by promoting HIF-1α hydroxylation-a prerequisite step for HIF-1α degradation. Deficiency of IPMK elicits enrichment of HIF-1α and VEGF, thereby inducing increased growth of blood vessels.
Methods
The authors declare that all supporting data are available within the article (and its Online Data Supplement).
Antibodies and Reagents
Anti-VEGF (cat No. ABS82), anti-pVHL (cat No. MABC14), and anti-NG2 (AB5320) antibodies were purchased from Millipore. What New Information Does This Article Contribute?
Nonstandard Abbreviations and Acronyms
• IPMK via its product IP5 inhibits angiogenesis.
• IP5 promotes PHD2-mediated HIF-1α hydroxylation, which is prerequisite for HIF-1α degradation.
• Deletion of IPMK/IP5 stabilizes HIF-1α, which increases VEGF production to induce angiogenesis.
HIF-1α activates the transcription of VEGF, which is a critical proangiogenic growth factor. In this study, we found that HIF-1α degradation is regulated by IPMK acting via its major product IP5. IP5 promotes PHD2-mediated prolyl hydroxylation of HIF-1α, which is prerequisite for ubiquitination and degradation of HIF-1α. Depletion of IP5 in IPMK mutant cells disrupts HIF-1α prolyl hydroxylation, which blocks HIF-1α ubiquitination/degradation. In IPMK mutant cells, aberrant accumulation of HIF-1α activates VEGF production, which induces angiogenesis. In IPMK mutant animals, substantial higher levels of HIF-1α/VEGF cause abnormal angiogenesis and leaky brain blood vessels. IP5 may elicit beneficial responses in hypoxia-induced angiogenic diseases, such as retinal neovascularization and cancers. 
In Vitro Conditioned Media Assay
IPMK KO (knockout) or 1×10 6 WT MEFs were cultured for 24 hours; the cell-culture media were filtered (0.22 μm filter) and concentrated (ratio, 1:10) by ultracentrifugal filters (10 kDa, Millipore). The concentrated cell-culture media were added to EGM2 medium (ratio, 1:10) to suspend HUVECs (1×10 5 /mL). As controls, concentrated fresh DMEM was added to EGM2 medium. The HUVECs suspensions were then plated onto Matrigel. Photos were taken 4 hours later. 43 
In Vivo Matrigel Plug Assay
A 500-μl Matrigel preparation containing a mixture of 1×10 6 MEFs and 1×10 6 HUVECs was injected subcutaneously in the flank of a nude mouse (male, 8 weeks old; 6 mice per group). The plugs were excised 10 days later and stained with hematoxylin and eosin or immunofluorescence staining for MEFs (NG2) and HUVECs (CD31). 43 
Coculture Assay
WT or IPMK KO MEFs were planted into a cell-culture plate for 24 hours and grown to confluence. HUVECs stably expressing DsRed fluorescent protein were then plated on top of the MEFs. The blood vessel-like structures were then formed by HUVECs. Photographs were taken on the third day after coculture. 44 
Plasmid and Lentiviral Expression in Cultured Cells
The shRNA and scrambled control plasmids were from SigmaAldrich. The myc-tagged murine WT IPMK, IPMK K129A, IPMK K129A/S235A, and IPMK ΔNLS constructs were cloned to pCDH-EF1-MCS-T2A-copGFP vector (System Biosciences). The myc-tagged human WT IPMK, IPMK K146A, IPMK ΔNLS, and myc-tagged GFP (green fluorescent protein) constructs were cloned to pCDH-EF1-MCS-T2A-copGFP vector (System Biosciences). The GFP-tagged WT IPMK and IPMKΔNLS were cloned to pLVXAcGFP1-N1 vector (Clontech). The flag-tagged pVHL and HIF-1α genes were cloned to pLVX-AcGFP1-N1 vector (Clontech). The GST (glutathione S-transferase)-tagged GFP and PHD2 were cloned to pCDH-EF1-MCS-T2A-copGFP vector (System Biosciences). Lentivirus were generated by transfection of lenviviral vector together with pMD2.G and psPAX2 to HEK 293T/17 cells. 44 
RNA Isolation and Real-Time Polymerase Chain Reaction
Total RNA was isolated from cells using the RNeasy Mini Kit (Qiagen) and reverse transcribed to cDNA using SuperScript III (Invitrogen). Real-time quantitative polymerase chain reaction was performed with the TaqMan Gene Expression Master Mix and the Step One Plus instrument (Life Technologies). β-Actin was used as loading control.
Immunoprecipitation
The lysis buffer contained 50 mmol/L Tris-HCl (pH 7.4), 100 mmol/L NaCl, 0.5% Igepal CA630, 5 mmol/L MgCl 2 , protease inhibitors, and phosphatase inhibitor. Cells were lysed on ice, and the lysates were passed 20× through a 30-gauge needle with syringe. The cell lysates were then centrifuged at 13 000 g for 10 minutes at 4°C. The supernatants were collected. Protein concentrations were determined by using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) and equalized. Equal amount of whole cell lysates were precleared with protein A/G agarose (Santa Cruz Biotechnology) for 1 hour at 4°C. Then the supernatants were added with antibody and incubated overnight at 4°C followed by protein A/G agarose precipitation.
Western Blotting
The lysis buffer contained 20 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 1% NP-40, 1% sodium deoxycholate, 1 mmol/L EDTA and 1 mmol/L EGTA, protease inhibitors, and phosphatase inhibitor. IPMK KO MEFs were treated with 10 μM MG132 together with 50 μM of Ins(1,3,4,5)P4, Ins(1,4,5,6)P4, IP5, or IP6 for 4 hours. Cells were lysed on ice, and the lysates were sonicated on ice. The cell lysates were then centrifuged at 13 000 g for 10 minutes at 4°C. The supernatants were collected. Protein concentrations were determined by using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) and equalized. Equal amount of whole cell lysates was applied for Western blotting.
ELISA
MEFs (1×10 6 ) were cultured for 24 hours, and the cell-culture media were filtered with 0.22 μM filters. The VEGF concentrations in the cell-culture media were calculated using the mouse VEGF ELISA Kit (Life Technology). For blood VEGF, bloods were drawn from euthanized animals. VEGF concentrations in plasma were calculated using the mouse VEGF ELISA Kit (Life Technology).
Subcellular Fractionation
The cytosol and nuclear fractions were isolated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific).
Intracellular Inositol Phosphate Calculation
MEF cells were plated at 50% confluence, and 100 μCi [ 3 H]myo-inositol was added to the medium and cultured for 3 days. The inositol phosphates were separated by high-performance liquid chromatography. 45 
Immunostaining
Animals were perfused and fixed with 4% paraformaldehyde (wt/ vol). The brain slices were at cut at 30-μm thickness. Cultured cells were washed with PBS and fixed with 4% paraformaldehyde (wt/vol). Slides were blocked with 10% goat serum (vol/vol) for 10 minutes at room temperature, followed by incubation with primary antibody at 4°C overnight, and then, fluorescence-labeled secondary antibody for 1 hour at room temperature. Cell nucleus was stained with DAPI. Slides were mounted with ProLong Gold Antifade Mountant. Pictures were taken under confocal microscope (Zeiss LSM 700, National Institutes of Health Award No. S10 OD016374).
In Vitro Hydroxylation Assay
GST-tagged PHD2 and flag-tagged HIF-1α (full length) were expressed in IPMK KO MEF cells. Cells expressing flag-HIF-1α were exposed to February 2, 2018 1% O 2 for 4 hours, and then HIF-1α was isolated by flag-tag beads pull down. PHD2 was isolated by glutathione sepharose beads pull down; the GST was removed by PreScission Protease. HIF-1α protein (on beads) was incubated with recombinant PHD2 protein for 1 hour at room temperature. The reaction buffer contains 40 mmol/L Tris-HCl (pH 7.4), 100 mmol/L NaCl, 3 mmol/L MgCl 2 , 5 mmol/L ascorbate, 1.5 mmol/L FeCl 2 , 4 mmol/L α-ketoglutarate, and 2 mg/mL BSA; 20 μM of Ins(1,3,4,5)P4, Ins(1,4,5,6)P4, IP5, or IP6 was added to the reaction. HIF-1α on flag-tag beads was then washed with reaction buffer. The hydroxylation of HIF-1α was analyzed by Western blot. 46 
Evans Blue Dye Leakage
Evans blue dye (2% in saline) was administered intraperitoneally (80 μL), and animals were euthanized and perfused 2 hours after injection. Photographs of brain tissue were taken immediately after tissue isolation. Evans blue was extracted by homogenizing brain tissue in 50% trichloroacetic acid (wt/vol) solution and centrifuged at 16 000 g for 20 minutes. The supernatants were diluted with ethanol (1:3), and fluorescence was quantified by using a microplate fluorescence reader. Sample value was determined by using a standard curve of Evans blue (0.1-100 ng/mL in the same solvent). Result was shown as nanograms of Evans blue per milligram of tissue.
47

Statistical Analysis
Quantitative data are expressed as means with SEM. Data were analyzed by 1-way ANOVA or unpaired Student t test (2 tailed). P<0.05 was considered statistically significant. For nonquantitative data, results were representative of at least 3 independent experiments.
Results
Deletion of IPMK Induces Angiogenesis
To determine whether IPMK regulates angiogenesis, we assessed the ability of angiogenic factors produced by WT-or IPMK-deleted MEFs to stimulate tube formation by HUVECs, using either MEF-conditioned media (Online Figure IA 
Deletion of IPMK Increases VEGF Expression
Because VEGF is a major determinant of angiogenesis, 48 we assessed its levels in IPMK-deleted MEFs. In IPMK KO cells, VEGF mRNA and protein levels increase 4-fold and 2-fold, respectively ( Figure 1A and 1B) . The cell-culture medium of IPMK-deleted MEFs displays almost a 2-fold increase in VEGF levels ( Figure 1C ). By contrast, reexpressing IPMK in IPMK KOs reduces VEGF mRNA and protein levels by ≈60% ( Figure 1D through 1F) .
We explored the possibility that IPMK-associated alterations of VEGF expression mediate the influence of IPMK on angiogenesis ( Figure 1G ). Treatment with antibodies to neutralize VEGF abolishes the augmented angiogenesis associated with IPMK deletion, whereas antibody to neutralize PDGF has no effect ( Figure 1G ; Online Figure IH) . Thus, diminished IPMK increases angiogenesis by augmenting VEGF levels.
Regulation of VEGF by IPMK also occurs in HEK 293 cells wherein IPMK depletion by shRNA elicits a 6-fold increase of cellular VEGF mRNA and protein levels (Figure 2A through  2C) . In human fibroblasts, depletion of IPMK by shRNA also is associated with increases in VEGF levels ( Figure 2D ).
Regulation of VEGF by IPMK Requires Its Catalytic Activity
Deletion of IPMK depletes intracellular IP5; reexpression of IPMK rescues intracellular IP5 (Online Figure II) . In IPMKdeleted MEFs, reexpression of WT IPMK reduces VEGF levels, whereas catalytically inactive IPMK (K129A) and IPMK (K129A/S235A) are ineffective ( Figure 2E) . In experiments analyzing cell-culture medium, we confirm that the regulation of VEGF by IPMK requires catalytic activity ( Figure 2F ). Thus, IP5-a major product of IPMK-is critical for regulating VEGF.
IPMK Does Not Serve as a Transcription Factor for VEGF
IPMK is a nuclear protein 4 and has been reported to regulate gene transcription through kinase-dependent and independent mechanisms. [49] [50] [51] Deletion of its nuclear localization signal prevents nuclear localization of IPMK (Online Figure IIIA and IIIB), although IPMK lacking an nuclear localization signal is able to generate IP5 (Online Figure II) .
To determine whether IPMK is a transcription factor for VEGF, we overexpressed WT IPMK, IPMK without nuclear localization signal, or kinase-dead IPMK in HEK 293 cells. Overexpressing WT or mutant IPMK does not decrease VEGF protein levels in HEK 293 cells ( Figure 2G) . Similarly, overexpressing IPMK fails to decrease VEGF mRNA levels in both human fibroblasts and MEFs ( Figure 2H and 2I) . Thus, deletion of IPMK increases VEGF, whereas overexpressing IPMK does not decrease VEGF levels in WT cells.
Deletion of IPMK Increases HIF-1α
HIF-1α is a major determinant of angiogenesis, which acts by regulating VEGF transcription. 52, 53 However, HIF-1α is constantly degraded under normoxic conditions, as a result of O 2 -dependent hydroxylation and ubiquitination. 21, 23 Downregulation of HIF-1α hydroxylation or ubiquitination blocks its degradation and induces VEGF transcription. 54, 55 We assessed HIF-1α protein levels in IPMK-deleted cells. In MEFs, IPMK deletion leads to substantial increases in HIF-1α protein levels ( Figure 3A through 3D) . The gene expression level of HIF-1α (tested by real-time polymerase chain reaction), however, does not change in IPMK KO cells (Online Figure IIIC) . HIF-2α also regulates VEGF transcription and induces angiogenesis. 56 However, HIF-2α is not detectable in WT or IPMK KO MEFs used in this study ( Figure 3A and 3C ). Knocking down IPMK by shRNA transfection in HEK 293 cells elicits increases in HIF-1α protein levels ( Figure 3E and 3F) . The augmentation of HIF-1α in IPMK-deleted MEFs is diminished by reexpressing WT IPMK but not catalytically inactive IPMK (IPMK lysine to alanine mutation [KA] or IPMK KA/serine to alanine mutation [SA]) protein ( Figure 3G and 3H) . Overexpressing WT IPMK in HEK 293 cells suppresses hypoxia-induced accumulation of HIF-1α and HIF-2α, whereas the kinase-defective IPMK (KA) does not decrease HIF-1α or HIF-2α protein levels ( Figure 3I and 3J) . Thus, the features of IPMK required for regulation of HIF-1α are essentially the same as those required for influencing angiogenesis and VEGF. Expression of IPMK ΔNLS also decreases hypoxia-induced HIF-1α and HIF-2α protein levels in HEK 293 cells ( Figure 3I and 3J) . We examined the expression levels of HIF-targeted genes in WT and IPMK KO MEFs (Online Figure IV) . The gene expression levels of ANGPT2 (angiopoietin 2), ANGPTL4 (angiopoietin-like 4), KitL (kit ligand), EGLN1 (egl-9 family HIF-1), Ero1L (endoplasmic oxidoreductin-1-like protein), SDF1 (stromal cell-derived factor 1), PGK1 (phosphoglycerate kinase 1), PDK1 (pyruvate dehydrogenase kinase 1), SLC2A3 (solute carrier family 2, facilitated glucose transporter member 3), BNIP3 (BCL2/adenovirus E1B 19 kDa proteininteracting protein 3), and LDHA (L-lactate dehydrogenase A chain) are increased in the IPMK KOs (Online Figure IV) .
HIF-1α Mediates the Regulation of VEGF Expression by IPMK
We confirmed that HIF-1α mediates the effect of IPMK on VEGF expression by depleting HIF-1α via shRNA transfection, which abolishes the upregulation of VEGF levels Figure 4A and 4B) . Knocking down HIF-2α by shRNA transfection in IPMK-deleted MEFs does not decrease VEGF levels, which is consistent with the lack of HIF-2α expression in these MEFs (Online Figure VA) . Further evidence implicating HIF-1α in VEGF regulation by IPMK comes from the ability of 2-methoxyestradiol and PX-478, which are HIF-1α inhibitors, 57, 58 to prevent the increase in VEGF expression associated with IPMK deletion (Figure 4C and 4D) . Thus, the regulation of VEGF by IPMK is through inhibition of HIF-1α. 
IP5 Induces HIF-1α Degradation
The negative regulation of HIF-1α requires IPMK catalytic activity. Deletion of IPMK abolishes the generation of IP5
and IP6 (Online Figure II) . It has been reported that IP6-the downstream product of IP5-inhibits angiogenesis. 59 To test the possibility that IP6 regulates HIF-1α, we depleted endogenous IP6 production by knocking down IP5K in HEK 293 cells ( Figure 4E and 4F). IP5K deletion does not increase HIF-1α ( Figure 4E) ; instead, it inhibits hypoxia-induced HIF-1α and HIF-2α expression ( Figure 4G and 4H) . Intriguingly, the alteration of HIF-1α expression in IP5K-deleted cells is similar to IPMK overexpression, which conceivably produces a large amount of IP5. It is noteworthy that an exceptionally high level of IP5 accumulates in IP5K-depleted cells ( Figure 4F) . Thus, IP5, rather than IP6, negatively regulates HIF-1α expression.
Decreased HIF-1α Ubiquitination in IPMK-Deleted Cells
We tested the possibility that IPMK physically associates with HIF-1α. However, we fail to detect binding of these 2 proteins to each other (Online Figure VB and VC) . Thus, IPMK does not seem to influence HIF-1α via direct interactions. HDAC1 (histone deacetylase) and HDAC3 stabilize HIF-1α 60 and are also regulated by inositol phosphates. 6, 61 In our experiments, depleting HDAC1 and HDAC3 fails to block the increase of VEGF and HIF-1α levels in the IPMK KOs, suggesting that these HDACs do not mediate the regulation of HIF-1α by IPMK (Online Figure VD and VE) .
The ubiquitin E3 ligase pVHL mediates degradation of HIF-1α, 15 which prompted us to explore a role for pVHL in the actions of IPMK on HIF-1α. In WT cells, depletion of pVHL by shRNA elevates HIF-1α levels ( Figure 5A and 5B). In IPMK KO cells, however, pVHL depletion fails to augment HIF-1α levels. HIF-1α is elevated in the IPMK KO cells to levels similar to cells with pVHL depletion. These findings fit with the possibility that the function of pVHL is disrupted in IPMK KO cells.
We directly examined the ubiquitination of HIF-1α in whole cell lysates and nuclear extracts ( Figure 5C and 5D ). Whereas proteasomal inhibition with MG132 increases the levels of ubiquitinated HIF-1α in WT cells, ubiquitination of HIF-1α is markedly diminished in IPMK-deleted MEFs. This implies that function of pVHL is disrupted in IPMK KO cells. These findings also fit with the well-supported notion that pVHL is the principal E3 ligase responsible for degradation of HIF-1α. 15, 24, 25 pVHL shuttles between nucleus and cytoplasm, raising the possibility that IPMK might play a role in such a shuttling. 62 However, our failure to detect any direct binding of pVHL and IPMK does not support such a possibility (Online Figure IVA and IVB) .
Ubiquitination of HIF-1α requires direct binding by pVHL. 28 This binding is lost in IPMK KO cells ( Figure 5E ). We explored whether the products of IPMK activity might be responsible for promoting pVHL/HIF-1α binding. Such binding is reinstated by IP5 but not by IP6, either of the IP4 isomers, PIP2 (phosphatidylinositol 4 5-bisphosphate), or PIP3 (phosphatidylinositol 3 4 5-trisphosphate; Figure 5F and 5G). The selective effect of IP5 is evident whether we immunoprecipitate pVHL or HIF-1α. The action of IP5 occurs at physiological concentrations with effects evident at 5 μM and maximal at 20 to 50 μM (Figure 5H and 5I) . Thus, it appears that generation of IP5 by IPMK is required for pVHL to mediate ubiquitination of HIF-1α. These findings are consistent with our observation that IP5, but not IP6, decreases HIF-1α levels (Figure 4 ).
IP5 Promotes HIF-1α Prolyl Hydroxylation
It has been reported that IP4 serves as intermolecular glue for HDAC complex assembly. 6 The structural basis of the HIF-1α/ pVHL complex precludes the possibility that IP5 serves such a function for HIF-1α/pVHL. 29, 30 HIF-1α prolyl hydroxylation is required for the HIF-1α/pVHL interaction. 24, 25 Hydroxylated HIF-1α levels are substantially decreased in nuclear extracts from IPMK KO MEFs ( Figure 6A ). The decrease of HIF-1α hydroxylation is further confirmed by immunoprecipitation of HIF-1α from MEFs, in which degradation of hydroxylated HIF-1α is blocked by MG132-a proteasome inhibitor ( Figure 6B ). Overexpression of IPMK significantly increases HIF-1α hydroxylation ( Figure 6C ). Further evidence that HIF-1α hydroxylation is regulated by IPMK is that WT but not IPMK KO MEFs degrade HIF-1α when the WT form of HIF-1α is overexpressed. Accordingly, HIF-1α accumulation is augmented in IPMK KO cells ( Figure 6D) . However, the difference between HIF-1α protein levels in WT and IPMK KO cells is decreased when the prolyl hydroxylation sites of HIF-1α are mutated to alanine (P402A/P564A). Furthermore, overexpression of IPMK decreases hypoxia-induced WT but not mutant HIF-1α ( Figure 6E ). Thus, IPMK regulates HIF-1α stability by promoting HIF-1α prolyl hydroxylation.
HIF-α prolyl hydroxylation is catalyzed by a family of 3 PHD-containing enzymes. 32, 33 We performed immunoprecipitation to test whether IPMK physically associates with PHDs. IPMK and PHDs do not pull down each other (Online Figure  VIC and VID) . Thus, IPMK does not directly interact with PHDs.
HIF-1α is mainly hydroxylated by PHD2; however, the accumulation of HIF-1α is not because of alteration of PHD2. Both the gene (EGLN1, which encodes PHD2; Online Figure IV ) and protein (Online Figure VIIA) levels are increased in IPMK KO cells. Thus, it is possible that the catalytic activity of PHD2 is inhibited in IPMK-deleted cells. Because the EGLN1 gene encoding PHD2 is an HIF target gene, 63 the increased PHD2 expression in IPMK KO cells is likely because of increased HIF-1α levels. Accordingly, we tested whether HIF-1α prolyl hydroxylation can be rescued by IP5. Treating IPMK-deleted cells with IP5 but not isomers of IP4 or IP6 increases HIF-1α hydroxylation ( Figure 6F ). HIF-1α prolyl hydroxylation is restored by IP5 at physiological concentrations (20-50 μM; Figure 6G ).
We tested whether the increased hydroxylation induced by IP5 is through promoting HIF-1α/PHD2 interaction by immunoprecipitation of PHD2 and HIF-1α from WT and IPMK KO MEFs. Equal amounts of PHD2 and HIF-1α are pulled down by each other from WT and IPMK KO cells, indicating that IP5 does not affect PHD2/HIF-1α interaction (Online Figure  VIIB) . We performed an in vitro assay to measure the effect of inositol phosphates on the hydroxylation of HIF-1α by PHD2. IP5 alone substantially increases HIF-1α hydroxylation ( Figure 6H ). Thus, IP5 acts as a specific activator of PHD2 enzyme activity and thereby promotes the O 2 -dependent degradation of HIF-1α. Knocking down PHD2 in WT preparations increases HIF-1α levels substantially but fails to do this in IPMK-deleted cells ( Figure 7A ). These findings indicate that the regulation of HIF-1α by IPMK is through PHD2.
We tested the possibility that IP5 binds with PHD2. We pulled down PHD2 and detected IP5 via high-performance liquid chromatography ( Figure 7B ). IP5 is pulled down by PHD2 but not GFP, indicating that IP5 binds to PHD2. February 2, 2018 Hypoxia Decreases IPMK and IP5 Levels IPMK protein levels are dramatically decreased when cells are exposed to hypoxia (Figures 3C and 7C) . The decrease of IPMK is evident with 30 minutes of hypoxia exposure ( Figure 7D ). IP5 levels also decline ≈40% during hypoxia ( Figure 7E ). Knocking down HIF-1α or HIF-2α does not prevent hypoxia-induced IPMK degradation ( Figure 7F ). Blocking new protein synthesis by cycloheximide treatment for 8 hours does not decrease IPMK protein levels ( Figure 7G ). Thus, IPMK is degraded in hypoxia condition, which does not depend on HIF-1α or HIF-2α.
Deletion of IPMK in Mouse Brain Increases HIF-1α/VEGF Levels and Vascularization
Because whole body KO of IPMK is lethal, we used NestinCre to KO IPMK in mouse brain and evaluated the in vivo by shRNA increases HIF-1α protein levels in WT (wild type) mouse embryonic fibroblasts (MEFs) but fails to augment HIF-1α protein levels in IPMK KO (knockout) cells. C, HIF-1α was immunoprecipitated from the lysates of whole cells that were exposed to either hypoxia (1% O 2 ) or MG132 (10 μM) for 4 h. Ubiquitination of HIF-1α is markedly diminished in IPMK KO MEFs. D, HIF-1α was immunoprecipitated from the nuclear fraction of MEFs that were exposed to either hypoxia (1% O 2 ) or MG132 (10 μM) for 4 h. HIF-1α ubiquitination is substantially decreased in IPMK KO MEFs. E, MEFs were treated with 10-μM MG132 for 4 h; HIF-1α and pVHL were then immunoprecipitated. The physical association of pVHL and HIF-1α is disrupted in IPMK KO cells. F, Flag-pVHL was immunoprecipitated from lysates of IPMK KO cells that were treated with 50-μM Ins(1,3,4,5)P4, Ins(1,4,5,6)P4, IP5, IP6, PtdIns(4,5) P2, or PtdIns(3,4,5)P3. The interaction of pVHL and HIF-1α is rescued by IP5. G, HIF-1α was immunoprecipitated from the same lysates described in F. IP5 increases the binding of pVHL with HIF-1α. H, Flag-pVHL was immunoprecipitated from IPMK KO cell lysates to which were added different concentrations of IP5. IP5 restores the association of HIF-1α with pVHL. I, HIF-1α was immunoprecipitated from the same lysates described in H. IP5 restores the association of HIF-1α with pVHL. ctrl indicates control.
effect of IPMK deletion. In mice with Nestin-Cre-mediated deletion of IPMK, blood levels of VEGF are significantly increased ( Figure 8A ). In IPMK-deleted cerebral cortex, both HIF-1α and VEGF levels are greatly enhanced ( Figure 8B) . Consistently, the expression of HIF-1α target genes, ANGPT2, 64 and EPO (erythropoietin) 65 is increased in IPMK KO cerebral cortex ( Figure 8C and 8D) . The expression of other HIF-targeted genes, such as ANGPTL4, KitL, EGLN1, LDHA, and PGK1, is also increased in the IPMK KO mouse brains (Online Figure VIIC) . Vascular density is much higher in IPMK KO cerebral cortex ( Figure 8E and 8F) . Enhanced blood vessel density is also observed in the IPMK-deleted cerebellum ( Figure 8G and 8H) . Thus, IPMK KO in vivo increases HIF-1α and VEGF expression and stimulates vascularization. Pathologically elevated VEGF levels increase blood vessel permeability and jeopardize blood-brain barrier. 66, 67 Accordingly, we examined the pericyte coverage of brain blood vessels by staining PDGF receptor β for pericytes and CD31 for endothelial cells ( Figure 8I ). There is a substantial decrease of pericyte coverage In IPMK KOs ( Figure 8I and 8J) , indicating that the blood-brain barrier is disrupted. Increased leakage of blood vessels in IPMK KOs is evident in brain tissue stained by Evans blue (Figure 8K ), which further confirms the disruption of the blood-brain barrier in IPMK KOs.
Discussion
Our study establishes that IPMK physiologically inhibits angiogenesis under normoxic conditions by decreasing HIF-1α and VEGF expression (Online Figure VIII) . IPMK generates IP5, which promotes HIF-1α degradation by increasing HIF-1α hydroxylation, which is a prerequisite for HIF-1α ubiquitination and degradation. 24, 25, 27 Thus, depleting IP5 levels by IPMK deletion increases HIF-1α and VEGF expression and induces angiogenesis. HIF-1α is a major determinant of angiogenesis by activating transcription of the VEGF gene, which encodes a critical proangiogenic growth factor. 68 Abnormal enrichment of HIF-α and VEGF leads to increased vascularization in hemangioblastomas and renal cell carcinomas in patients with von Hippel-Lindau disease, 15, 16, 54 ischemic retinopathy, 17 and many advanced human cancers. 18, 19 Deletion of IPMK in mouse brain elicits increased levels of HIF-1α/VEGF and substantial higher blood vessel densities. In addition, increased VEGF disrupts the blood-brain barrier and causes brain blood vessel leakage in IPMK KOs. Clinically, IPMK mutation is associated with a form of intestinal carcinoid tumor. 69 IPMK has been shown to regulate gene transcription in both kinase-dependent and independent manners. [49] [50] [51] The regulation of VEGF transcription by IPMK requires its catalytic activity. IPMK does not directly regulate VEGF transcription. Instead, it regulates the stability of HIF-1α, which induces VEGF transcription. IP5-a major product of IPMK-facilitates HIF-1α hydroxylation, ubiquitination, and degradation.
IP5 has been reported to inhibit angiogenesis by inhibiting the endothelial cell PI3K/Akt pathway. 8 However, the regulation of HIF-1α and VEGF by IPMK/IP5 is not through inhibition of the PI3K/Akt pathway because Akt activity is decreased rather than increased in IPMK KO cells that lack IP5. 70 In our study, the antiangiogenic effect of IP5 is through inhibition of VEGF production by fibroblasts or neural cells, rather than endothelial cells, which are the targets of VEGF.
HIF-2α is homologous to HIF-1α and also activates VEGF transcription. 56 HIF-2α is selectively expressed in certain tissues, whereas HIF-1α is expressed ubiquitously. 23 HIF-2α is not detectable in the MEFs used in this study. However, the influence of IPMK on HIF-2α in HEK 293 cells is similar to that of HIF-1α.
The regulation of HIF-1α by IPMK differs from other modes of regulation, which require direct protein-protein interactions. 41, 71 IPMK does not physically associate with HIF-1α, PHD2, or pVHL. Instead, IP5-a major product of IPMK-mediates HIF-1α prolyl hydroxylation and degradation. IP5 binds with PHD2, and thus may act as an allosteric activator.
Overexpressing IPMK increases IP5 levels and decreases hypoxia-induced expression of HIF-1α. Deletion of IP5K also increases IP5 levels and decreases hypoxia-induced HIF-1α. Thus, enhancement of IP5 might be beneficial for the treatment of hypoxia-induced angiogenic diseases. Indeed, IP5 has been shown to inhibit angiogenesis and tumor growth. 7, 8 
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